Antiphospholipid antibodies and thrombosis
EAS Academy. Lackner K. 11/29/17; 202885 Topic: Arterial wall & AS
Prof. Dr. Karl Lackner
Prof. Dr. Karl Lackner

Access to Premium Content is a benefit of Individual EAS membership. Apply for membership

Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android

For any questions contact us at

About this activity
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
The advanced course on Atherothrombosis that was held in Vienna in November 2017 provided a comprehensive overview of the basic principles of atherothrombosis as well the vascular alterations leading to it. Both clinical and basic science experts gave stimulating presentations on topics ranging from vascular inflammation to plaque vulnerability and clinical aspects of atherothrombosis. The contribution of the vessel wall and plaque composition as well as the role of all major vascular cells and humoral factors in atherothrombosis were discussed. Finally, novel concepts such as immunothrombosis, the role of the gut microbiome, as well as systemsbiology approaches in cardiovascular medicine were presented.
After viewing this presentation, the participant will be able to:
- Recognize the antiphospholipid syndrome (APS) and its clinical manifestation
- Understand the research approaches aimed at defining the pathogenic mechanisms involved in APS
- Recognize that there are different antiphospholipid antibodies (aPL) which activate different cellular signalling pathways and may have different pathogenic effects
- Discuss the therapeutic consequences implied by basic research on aPL
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies